Tranexamic acid as a therapeutic option for melasma management: meta-analysis and systematic review of randomized controlled trials

References

• González-Molina V, Martí-Pineda A, González N. Topical treatments for melasma and their mechanism of action. J Clin Aesthet Dermatol. 2022; May15(5):1–13.
   Google Scholar
• Kim HJ, Moon SH, Cho SH, et al. Efficacy and safety of tranexamic acid in melasma: a meta-analysis and systematic review. Acta Derm Venereol. 2017;97(7):776–781. doi:10.2340/00015555-2668.
   PubMed Web of Science ®Google Scholar
• Kwon SH, Hwang YJ, Lee SK, et al. Heterogeneous pathology of melasma and its clinical implications. Int J Mol Sci. 2016;17(6):17. doi:10.3390/ijms17060824.
   Web of Science ®Google Scholar
• Austin E, Nguyen JK, Jagdeo J. Topical treatments for melasma: a systematic review of randomized controlled trials. J Drugs Dermatol. 2019;18(11):S1545961619P1156X. http://europepmc.org/abstract/MED/31741361
   PubMed Web of Science ®Google Scholar
• Wang JV, Jhawar N, Saedi N. Tranexamic acid for melasma: evaluating the various formulations. J Clin Aesthet Dermatol. 2019;12(8):E73–E74.
   PubMedGoogle Scholar
• Fatima S, Braunberger T, Mohammad TF, et al. The role of sunscreen in melasma and postinflammatory hyperpigmentation. Indian J Dermatol. 2020;65(1):5–10. doi:10.4103/ijd.IJD_295_18.
   PubMed Web of Science ®Google Scholar
• Zhang L, Tan W-Q, Fang Q-Q, et al. Tranexamic acid for adults with melasma: a systematic review and meta-analysis. Biomed Res Int. 2018;2018:1683414. doi:10.1155/2018/1683414.
   PubMed Web of Science ®Google Scholar
• Kaur A, Bhalla M, Pal Thami G, et al. Clinical efficacy of topical tranexamic acid with microneedling in melasma. Dermatologic Surg. 2020;46(11):e96–e101. https://journals.lww.com/dermatologicsurgery/fulltext/2020/11000/clinical_efficacy_of_topical_tranexamic_acid_with.11.aspx
   PubMed Web of Science ®Google Scholar
• Khurana VK, Misri RR, Agarwal S, et al. A randomized, open-label, comparative study of oral tranexamic acid and tranexamic acid microinjections in patients with melasma. Indian J Dermatol Venereol Leprol. 2019;85(1):39–43. doi:10.4103/ijdvl.IJDVL_801_16.
   PubMed Web of Science ®Google Scholar
• Minni K, Poojary S. Efficacy and safety of oral tranexamic acid as an adjuvant in indian patients with melasma: a prospective, interventional, single-Centre, triple-blind, randomized, placebo-control, parallel group study. J Eur Acad Dermatol Venereol. 2020;34(11):2636–2644. doi:10.1111/jdv.16598.
   PubMed Web of Science ®Google Scholar
• Padhi T, Pradhan S. Oral tranexamic acid with fluocinolone-Based triple combination cream versus fluocinolone-Based triple combination cream alone in melasma: an open labeled randomized comparative trial. Indian J Dermatol. 2015;60(5):520. doi:10.4103/0019-5154.164416.
   PubMed Web of Science ®Google Scholar
• Jia Z, Tian K, Zhong Y, et al. Effectiveness of combination therapy of broadband light and intradermal injection of tranexamic acid in the treatment of chloasma. J Cosmet Dermatol. 2023;22(5):1536–1544. doi:10.1111/jocd.15632.
   PubMed Web of Science ®Google Scholar
• Li Y, Yao C, Zhang H, et al. Efficacy and safety of 755-nm picosecond alexandrite laser with topical tranexamic acid versus laser monotherapy for melasma and facial rejuvenation: a multicenter, randomized, double-blinded, split-face study in chinese patients. Lasers Med Sci. 2022;37(7):2879–2887. doi:10.1007/s10103-022-03566-4.
   PubMed Web of Science ®Google Scholar
• Qu Y, Wang F, Liu J, et al. Clinical observation and dermoscopy evaluation of fractional CO2 laser combined with topical tranexamic acid in melasma treatments. J Cosmet Dermatol. 2021;20(4):1110–1116. doi:10.1111/jocd.13992.
   PubMed Web of Science ®Google Scholar
• Zhao H, Li M, Zhang X, et al. Comparing the efficacy of myjet-assisted tranexamic acid and vitamin C in treating melasma: a split-face controlled trial. J Cosmet Dermatol. 2020;19(1):47–54. doi:10.1111/jocd.13112.
   PubMed Web of Science ®Google Scholar
• Li T, Yan X, Ting L, et al. Observation on the effect of Nd: YAG 1064nm laser combined with topical tranexamic acid on chloasma. In 2020 International Conference on Public Health and Data Science (ICPHDS); 2020 Nov 20; Guangzhou, China. IEEE; 2020. p. 302–306. https://ieeexplore.ieee.org/abstract/document/9361947
   Google Scholar
• Xu Y, Ma R, Juliandri J, et al. Efficacy of functional microarray of microneedles combined with topical tranexamic acid for melasma: a randomized, self-controlled, split-face study. Medicine (Baltimore). 2017;96(19):e6897. May doi:10.1097/MD.0000000000006897.
   PubMed Web of Science ®Google Scholar
• Gamea MM, Kamal DA, Donia AA, et al. Comparative study between topical tranexamic acid alone versus its combination with autologous platelet rich plasma for treatment of melasma. J Dermatolog Treat. 2022;33(2):798–804. doi:10.1080/09546634.2020.1781755.
   PubMed Web of Science ®Google Scholar
• Elkamshoushi AM, Romisy D, Omar SS. Oral tranexamic acid, hydroquinone 4% and low-fluence 1064 nm Q-switched Nd: YAG laser for mixed melasma: clinical and dermoscopic evaluation. J Cosmet Dermatol. 2022;21(2):657–668. doi:10.1111/jocd.14140.
   PubMed Web of Science ®Google Scholar
• Badran AY, Ali AU, Gomaa AS. Efficacy of topical versus intradermal injection of tranexamic acid in egyptian melasma patients: a randomised clinical trial. Australas J Dermatol. 2021;62(3):e373–9–e379. doi:10.1111/ajd.13575.
   Web of Science ®Google Scholar
• Zaky MS, Obaid ZM, Khalil EA, et al. Microneedling-assisted topical tranexamic acid solution versus 4% hydroquinone for treating melasma: a split-face randomized study. J Cosmet Dermatol. 2021;20(12):4011–4016. doi:10.1111/jocd.14440.
   PubMed Web of Science ®Google Scholar
• Tawfic SO, Abdel Halim DM, Albarbary A, et al. Assessment of combined fractional CO2 and tranexamic acid in melasma treatment. Lasers Surg Med. 2019;51(1):27–33. doi:10.1002/lsm.23032.
   PubMed Web of Science ®Google Scholar
• Behrangi E, Shemshadi M, Ghassemi M, et al. Comparison of efficacy and safety of tranexamic acid mesotherapy versus oral tranexamic acid in patients with melasma undergoing Q-switched fractional 1064-nm Nd: YAG laser: a blinded RCT and follow-up. J Cosmet Dermatol. 2022;21(1):279–289. doi:10.1111/jocd.14496.
   PubMed Web of Science ®Google Scholar
• Karrabi M, Mansournia MA, Sharestanaki E, et al. Clinical evaluation of efficacy and tolerability of cysteamine 5% cream in comparison with tranexamic acid mesotherapy in subjects with melasma: a single-blind, randomized clinical trial study. Arch Dermatol Res. 2021;313(7):539–547. doi:10.1007/s00403-020-02133-7.
   PubMed Web of Science ®Google Scholar
• Shamsi Meymandi S, Mozayyeni A, Shamsi Meymandi M, et al. Efficacy of microneedling plus topical 4% tranexamic acid solution vs 4% hydroquinone in the treatment of melasma: a single-blind randomized clinical trial. J Cosmet Dermatol. 2020;19(11):2906–2911. doi:10.1111/jocd.13392.
   PubMed Web of Science ®Google Scholar
• Basit A, Rahman A, Uddin R. Oral tranexemic acid with triple combination cream (flucinolone + hydroquinone + tretinoin) versus triple combination cream alone in treatment of melasma. J Ayub Med Coll Abbottabad-Pakistan. 2021 Apr 1;33(2):293–298.
   Google Scholar
• Shihab N, Prihartono J, Tovar-Garza A, et al. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma. Australas J Dermatol. 2020;61(3):237–242. doi:10.1111/ajd.13267.
   PubMed Web of Science ®Google Scholar
• Shin JU, Park J, Oh SH, et al. Oral tranexamic acid enhances the efficacy of low-fluence 1064-Nm quality-switched Neodymium-Doped yttrium aluminum garnet laser treatment for melasma in koreans: a randomized, prospective trial. Dermatol Surg. 2013;39(3 Pt 1):435–442. doi:10.1111/dsu.12060.
   PubMed Web of Science ®Google Scholar
• Rao SK, Rajashekar TS, Ashraf A. Efficacy of intralesional tranexamic acid in melasma: assessment with melasma area severity index and dermatology quality of life index. Turkderm Turkish Arch Dermatology Venereol. 2022;56(2):58–63. doi:10.4274/turkderm.galenos.2022.42709.
   Web of Science ®Google Scholar
• Shin JU, Park J, Oh SH, et al. Oral tranexamic acid enhances the efficacy of low-fluence 1064-Nm quality-switched neodymium-doped yttrium aluminum garnet laser treatment for melasma in koreans: a randomized, prospective trial. Dermatologic Surg. 2013;39(3):435–442. doi:10.1111/dsu.12060.
   PubMed Web of Science ®Google Scholar
• Feng X, Su H, Xie J. Efficacy and safety of tranexamic acid in the treatment of adult melasma: an updated meta-analysis of randomized controlled trials. J Clin Pharm Ther. 2021;46(5):1263–1273. doi:10.1111/jcpt.13430.
   PubMed Web of Science ®Google Scholar